A Pilot, Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP).

This trial is for males who have a diagnosis of lower urinary tract symptoms and/or urinary retention due to benign prostatic enlargement causing bladder outlet obstruction.

A randomised, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer. 

For Psychometric evaluation of a Patient-Reported Symptom Index for Non-Muscle Invasive Bladder Cancer: Field Testing

TRUS Project – Identifying multi-omic markers (genomic, epigenomic, transcriptomic) to predict risk of prostate cancer in NZ men

Assessment of social and physical post-operative recovery after Robot Assisted Laparoscopic Prostatectomy (RALP) and Retropubic Radical prostatectomy (RRP)

A Phase 3 Randomised, Placebo-controlled, Double-blind Study of Darolutamide plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects with Metastatic Hormone-sensitive Prostate Cancer (mHSPC).

Randomised, double-blind, placebo-controlled, multi-centre, phase 3 study to assess the efficacy, safety and immunogenicity of vaccination with ExPECMV in the prevention of invasive extra intestinal pathogenic ecoli disease in adults aged 60 years and older with a history of UTI in the last 2 years.